Globe Life (NYSE:GL) Updates FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 15.550-15.950 for the period, compared to the consensus estimate of 15.650. The company issued revenue guidance of -.

Globe Life Price Performance

Shares of NYSE:GL traded down $0.63 during trading on Wednesday, hitting $183.71. 899,555 shares of the company were exchanged, compared to its average volume of 550,475. Globe Life has a 1-year low of $122.48 and a 1-year high of $191.55. The company has a market capitalization of $14.26 billion, a P/E ratio of 12.70 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The business’s 50 day moving average is $167.76 and its 200-day moving average is $152.23.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts forecast that Globe Life will post 15.64 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Wall Street Analysts Forecast Growth

GL has been the subject of a number of analyst reports. Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday. Morgan Stanley boosted their target price on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. JPMorgan Chase & Co. raised their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research note on Tuesday. Wells Fargo & Company increased their price target on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Finally, TD Cowen lifted their price target on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $187.60.

Insider Transactions at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the transaction, the chief executive officer owned 58,451 shares of the company’s stock, valued at $8,994,439.88. The trade was a 7.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the sale, the director owned 16,621 shares in the company, valued at approximately $2,979,148.04. This trade represents a 33.19% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 124,187 shares of company stock valued at $19,529,414. Company insiders own 2.11% of the company’s stock.

Globe Life News Roundup

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported second-quarter net operating income of $3.61 per share, up from $3.27 a year ago, and revenue of $1.60 billion slightly beat estimates, showing continued business strength. GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
• Positive Sentiment: Several analysts turned more bullish on the stock, including TD Cowen raising its price target to $225 and JPMorgan lifting its target to $201, signaling confidence in Globe Life’s earnings outlook. Benzinga analyst update
• Neutral Sentiment: The company updated FY 2026 EPS guidance to $15.55-$15.95, which is broadly in line with the consensus estimate of $15.65 and suggests no major change to the longer-term outlook.
• Negative Sentiment: Globe Life’s quarterly EPS of $3.61 missed analyst expectations of $3.67, which may be weighing on the stock despite the revenue beat. Press Release

Institutional Investors Weigh In On Globe Life

Several institutional investors have recently added to or reduced their stakes in GL. NorthRock Partners LLC bought a new position in Globe Life during the 3rd quarter valued at approximately $208,000. Harvest Fund Management Co. Ltd increased its stake in shares of Globe Life by 755.0% during the third quarter. Harvest Fund Management Co. Ltd now owns 1,026 shares of the company’s stock valued at $147,000 after buying an additional 906 shares during the period. Quadrant Capital Group LLC purchased a new position in shares of Globe Life during the third quarter valued at approximately $136,000. AlphaCentric Advisors LLC bought a new position in shares of Globe Life during the fourth quarter valued at approximately $118,000. Finally, Johnson Financial Group Inc. lifted its stake in Globe Life by 272.6% in the third quarter. Johnson Financial Group Inc. now owns 734 shares of the company’s stock worth $105,000 after acquiring an additional 537 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.